1. Home
  2. ORMP

as of 02-18-2026 1:34pm EST

$3.34
+$0.14
+4.37%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Founded: 2002 Country:
N/A
Employees: N/A City: NEW YORK
Market Cap: 134.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 186.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
7.62%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $1.82 - $3.71 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: 3.12 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered ORMP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold
Model Accuracy: 68.66%
68.66%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: